Optic Nerve Glioma Companies

ID: MRFR/Pharma/2808-HCR

90 Pages

Rahul Gotadki

October 2025

Optic nerve glioma, also known as optic pathway glioma, is a rare type of tumor that affects the optic nerve. These tumors are most commonly seen in children and are often associated with neurofibromatosis type 1 (NF1). Treatment options for optic nerve gliomas may include surgery, chemotherapy, and radiation therapy. There might not be specific companies exclusively dedicated to optic nerve glioma, but pharmaceutical and biotechnology companies may be involved in developing treatments for gliomas and related conditions.

Summary Table of Contents Segmentation Download PDF

Optic Nerve Glioma Market

Latest Optic Nerve Glioma Companies Updates:

Biocompare, Bio-Rad Laboratories, and Miltenyi Biotec are involved in developing diagnostic tools and reagents.

Pharmaceutical giants like Novartis and Pfizer are exploring targeted therapies for the treatment.

Medical device companies like Philips and Siemens Healthcare are working on advanced imaging technologies for accurate diagnosis.

List of Optic Nerve Glioma Key companies in the market: